prostate-cancer

Documents about prostate-cancer

• A Phase 1 Study of Pegilodecakin (LY3500518) in Participants With Advanced Solid Tumors#18576ClinicalTrials.gov
• Experimental Therapeutic Cancer Vaccine Created In-situ in Patients With Stage II-Stage IV Cancer#18621ClinicalTrials.gov
• Non-fucosylated Anti-CTLA-4 (BMS-986218) + Degarelix Acetate vs. Degarelix Acetate Alone in Men With High-risk Localized Prostate Cancer#28331ClinicalTrials.gov
• Castration Compared to Castration Plus Metformin as First Line Treatment for Patients With Advanced Prostate Cancer#67843ClinicalTrials.gov
• Biparametric MRI for Detection of Significant Prostate Cancer#121393ClinicalTrials.gov
• FK-PC101 as Adjuvant Therapy for Men With High-Risk Prostate Cancer#123529ClinicalTrials.gov
• Reduction of Prostate Biopsy Morbidity#329542ClinicalTrials.gov
• A Clinical Research of CAR T Cells Targeting EpCAM Positive Cancer#332745ClinicalTrials.gov
• Phase I/II Study of Immunotherapy Combination BN-Brachyury Vaccine, M7824, N-803 and Epacadostat (QuEST1)#332767ClinicalTrials.gov
• Pioglitazone and Insulin Resistance in ADT#337095ClinicalTrials.gov
• Vaccine Therapy Plus Sargramostim and Interleukin-2 Compared With Nilutamide Alone in Treating Patients With Prostate Cancer#343709ClinicalTrials.gov
• Open Label Study of Sipuleucel-T in Metastatic Prostate Cancer#346906ClinicalTrials.gov
• Reconstitution of a Human Immune System in a Patient Derived Xenograft (PDX) Model of Genitourinary (GU) Cancers#346922ClinicalTrials.gov
• IL-15 Superagonist With or Without Vaccine in Biochemically Recurrent Prostate Cancer After Previous Stereotactic Body Radiation Therapy#353341ClinicalTrials.gov
• Repurposing Metformin as Anticancer Drug: in Advanced Prostate Cancer#363579ClinicalTrials.gov
• PSA Vaccine Therapy in Treating Patients With Advanced Prostate Cancer#363671ClinicalTrials.gov
• Docetaxel in Combination With GVAX ® Immunotherapy Versus Docetaxel and Prednisone in Prostate Cancer Patients#366586ClinicalTrials.gov
• Evaluation of Xaluritamig in High-Risk, Biochemically Recurrent, Non-metastatic Castrate-sensitive Prostate Cancer#366604ClinicalTrials.gov
• The efficacy of immune checkpoint inhibitors in metastatic castration-resistant prostate cancer: A meta-analysis and reconstructed individual patient data analysis#4635Europe PMC

Related topics